Welcome Juliette Sabbatani, our new project manager at CQDM ! 🎉 Juliette Sabbatani is an innovative scientist with nearly ten years of experience in the pharmaceutical industry and drug discovery. A co-inventor on ten patents, she has led complex projects across academic, biotech, and startup environments. 🌟 Learn more about her : Juliette Sabbatani
CQDM is pleased to launch a call for ideas for our upcoming CQDM Connect-Pharma: Pitch Day. We are searching for world-class research on advanced in vitro and non-animal models that could revolutionize drug discovery and development to present to domain experts from leading global pharmaceutical organizations on March 19th, 2026. Our objective is to bring…
Montreal, November 28, 2025 – CQDM is proud to have presented the 2025 RSRI Innovation Award at the ADRIQ Innovation Awards Gala to Philippe Joubert, Yohan Bossé, Solutions de diagnostic BioMark, and their valued collaborators! They are being recognized for a collaborative project that is transforming lung cancer screening in Quebec. 🏆 Supported by CQDM…
Announcement Montreal, November 20, 2025 – CQDM is proud to announce the funding of two collaborative research projects that share a common goal: reinventing preclinical research by reducing the use of in vivo testing. Valued at a total of $1,145,874, these projects are made possible through a grant from the Government of Quebec awarded by…
Announcement Montreal, November 18, 2025 – CQDM is proud to announce funding for three collaborative research projects, each driven by a shared ambition: to advance therapeutic innovation and improve treatment options for complex diseases, including rare genetic disorders and metabolic conditions. With a total value of $2,248,158, these projects are made possible through a grant…
— Project funded through CQDM Quantum Leap program — Montréal, QUÉBEC, November 11, 2025 – CQDM and Saguaro Biosciences are proud to announce that the company has received more than $780,000 to further enhance ChromaLIVETM, the leading image-based profiling technology for AI-enabled drug discovery. ChromaLIVETM is a non-toxic and multichromatic dye that allows the generation…
Ready to transform the future of drug discovery and development with digitally enabled technologies and AI? The Merck Digital Sciences Studio (MDSS) is back and recruiting startups for its 9-month program in Canada! In partnership with Centech Mtl and CQDM, the program offers exclusive access to Merck experts, personalized mentoring from Entrepreneurs-in-Residence, high-level workshops, powerful…
Lutter contre les maladies respiratoires, en particulier dans les hôpitaux Montréal, Canada – October 8, 2025 – Glycovax Pharma today announced a strategic collaboration with the National Research Council of Canada (NRC) and the Faculty of Veterinary Medicine at the Université de Montréal to develop a glycoconjugate vaccine against Pseudomonas aeruginosa (Pa) infections. Funding for…
Announcement Montreal, October 6, 2025 – CQDM is proud to announce the funding of an artificial intelligence (AI) innovation project aimed at improving the diagnosis of pancreatic neuroendocrine tumors. This project, with a total value of $395,255, is led by two Quebec-based companies, Vega BioImagerie and Aurora mScope, in collaboration with the Centre hospitalier de…
Welcome to Koffi Locoh, our new Chief Accountant at CQDM! 🎉 Holder of a graduate diploma (DESS) in accounting from the Université de Sherbrooke, he earned his CPA designation in 2024. With more than 16 years of experience in accounting, including 12 years in accounting firms, he has strong expertise in team supervision, financial statement…